Fucoziff 50 Tablet contains Fluconazole 50mg, a well-established triazole antifungal agent widely used for the treatment and prevention of fungal infections caused by Candida and other susceptible organisms. It is commonly prescribed for oral candidiasis, vaginal yeast infections, and prophylaxis in immunocompromised patients.
Fluconazole exerts its antifungal action by inhibiting ergosterol synthesis, an essential component of the fungal cell membrane. The 50mg strength is suitable for mild infections, step-down therapy, and long-term prophylactic use, offering reliable efficacy with good tolerability.
For hospitals, clinics, and pharmaceutical distributors, Fucoziff 50 Tablet is a regularly prescribed antifungal medicine, frequently used across general medicine, gynecology, dermatology, and infectious disease departments. Continuous demand for antifungal therapy ensures consistent market movement.
Adding Fucoziff 50 Tablet to your product portfolio strengthens your antifungal and anti-infective segment, opening opportunities in hospital procurement, pharmacy distribution, institutional supply, export markets, and third-party manufacturing. Its broad clinical application and steady prescription pattern make it a commercially valuable product for pharmaceutical distributors.